GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma.
dc.authorid | 0000-0002-7059-1411 | |
dc.authorwosid | Lee, Kee-Joon/AAA-4090-2022 | |
dc.authorwosid | Graklanov, Vasko/AAB-8273-2020 | |
dc.authorwosid | Radinoff, Atanas/AAD-8721-2021 | |
dc.contributor.author | Ertan-Ahmed, Senem | |
dc.contributor.author | Kiehl, Michael G. | |
dc.contributor.author | Radinoff, Atanas | |
dc.contributor.author | Graklanov, Vasko | |
dc.contributor.author | Tzvetkov, Nikolay | |
dc.contributor.author | Mihaescu, Rodica | |
dc.contributor.author | Sung, Young Chul | |
dc.contributor.author | Turgut, Burhan | |
dc.date.accessioned | 2022-05-11T14:39:57Z | |
dc.date.available | 2022-05-11T14:39:57Z | |
dc.date.issued | 2019 | |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | |
dc.description | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL | |
dc.description.abstract | [No Abstract Available] | |
dc.description.sponsorship | Amer Soc Clin Oncol | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/8811 | |
dc.identifier.volume | 37 | |
dc.identifier.wos | WOS:000487345802410 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.institutionauthor | Turgut, Burhan | |
dc.language.iso | en | |
dc.publisher | Amer Soc Clinical Oncology | |
dc.relation.ispartof | Journal of Clinical Oncology | |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.title | GX-G3, a long-acting G-CSF, compared with pegfilgrastim in reducing duration of severe neutropenia after chemotherapy for non-Hodgkin's lymphoma. | |
dc.type | Conference Object |